SCHEMBL18885367

SCHEMBL18885367

CCC(C)c1cnc2cnn(C(C)CC)c2c1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.35
KMO O15229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16663602 0.72 KDM4E (0.34) HCAR3
SCHEMBL22419371 0.70 PDE1A (0.38)
SCHEMBL22358042 0.68 KMO (0.47) HCAR3KMO
SCHEMBL14467508 0.66 CYP1A2 (0.52)
SCHEMBL20251106 0.66 HCAR3 (0.37) HCAR3
SCHEMBL15340919 0.64 MAPK1 (0.32)
SCHEMBL18885373 0.64 CYP1A2 (0.36) HCAR3
SCHEMBL19453371 0.63 ALDH1A1 (0.34)
SCHEMBL20117056 0.62 KMO (0.48) HCAR3KMO
SCHEMBL3862440 0.62 RECQL (0.42) KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657033-B2 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease LYCERA CORPORATION (US) 2017-05-23 US disclosed